| 1 |
33218942 | Protective effect and mechanism of rebamipide on NSAIDs associated small bowel injury. | 2021 Jan |
1 |
| 2 |
25138760 | Inhibition by rebamipide of cytokine-induced or lipopolysaccharide-induced chemokine synthesis in human corneal fibroblasts. | 2014 Dec |
2 |
| 3 |
25705372 | Downregulation of IL-8, ECP, and total IgE in the tears of patients with atopic keratoconjunctivitis treated with rebamipide eyedrops. | 2014 |
3 |
| 4 |
23603753 | Rebamipide increases barrier function and attenuates TNFα-induced barrier disruption and cytokine expression in human corneal epithelial cells. | 2013 Jul |
1 |
| 5 |
20198424 | Management of recurrence of symptoms of gastroesophageal reflux disease: synergistic effect of rebamipide with 15 mg lansoprazole. | 2010 Dec |
2 |
| 6 |
20607584 | Rebamipide inhibits tumor necrosis factor-α-induced interleukin-8 expression by suppressing the NF-κB signal pathway in human umbilical vein endothelial cells. | 2010 Dec |
6 |
| 7 |
11855542 | Effect of rebamipide in treatment of Helicobacter pylori-associated duodenal ulcer: attenuation of chemokine expression and nitrosative damage. | 2002 Feb |
1 |
| 8 |
11454909 | Rebamipide inhibits ceramide-induced interleukin-8 production in Kato III human gastric cancer cells. | 2001 Aug |
5 |
| 9 |
9862763 | Inhibitory effect of rebamipide on the neutrophil adherence stimulated by conditioned media from Helicobacter pylori-infected gastric epithelial cells. | 1999 Jan |
3 |